A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC)

Walter M. Stadler,J. N. Swerdloff,K. Margolin,B. McCulloch,John A. Thompson

A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC)

2005

Walter M. Stadler
J. N. Swerdloff
K. Margolin
B. McCulloch
John A. Thompson

4669 Background: Metastatic RCC is poorly responsive to current available systemic therapies. Multiple genes thought to be important in RCC development and progression are inactivated by methylatio...

Keywords:

Pathology
Metastatic renal cell cancer
Phases of clinical research
Cancer research
Depsipeptide
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations